Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trials in psychiatry: should protocol deviation censor patient data?

P W Lavori1

  • 1Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data Sharing, Clinical Trials, and Biomarkers in Precision Oncology: Challenges, Opportunities, and Programs at the Department of Veterans Affairs.

Clinical pharmacology and therapeutics·2017
Same author

Two-year weight-loss maintenance in primary care-based Diabetes Prevention Program lifestyle interventions.

Nutrition & diabetes·2013
Same author

Eating attitudes in high school students in the Philippines: a preliminary study.

Eating and weight disorders : EWD·2002
Same author

Strengthening clinical effectiveness trials: equipoise-stratified randomization.

Biological psychiatry·2001
Same author

Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux.

The American journal of gastroenterology·2001
Same author

Design of Department of Veterans Affairs Cooperative Study no. 420: group treatment of posttraumatic stress disorder.

Controlled clinical trials·2001

Intent-to-treat analysis in psychiatry is challenged by patient non-adherence, leading to data censoring. Researchers should prioritize collecting complete follow-up data for all participants, irrespective of treatment adherence.

Area of Science:

  • Psychiatry
  • Clinical Trials Methodology
  • Biostatistics

Background:

  • Intent-to-treat (ITT) is a gold standard in clinical trials, analyzing participants based on initial randomization, not adherence.
  • Psychiatric outcome measurement often requires patient cooperation and can be compromised by treatment non-adherence.
  • Patient or clinician decisions to deviate from protocols can lead to data censoring, hindering strict ITT analysis.

Purpose of the Study:

  • To highlight the challenges of implementing strict intent-to-treat analysis in psychiatric clinical trials due to data censoring.
  • To review current statistical methods for analyzing non-randomly truncated data in psychiatric research.
  • To propose strategies for obtaining complete follow-up data in psychiatric studies.

Main Methods:

Related Experiment Videos

  • Review of clinical trial methodology recommendations for intent-to-treat analysis.
  • Analysis of the impact of patient non-adherence and data censoring on psychiatric outcome measurement.
  • Critique of current statistical approaches like 'last value' analysis and imputation methods.
  • Proposal for a modified approach to data collection in psychiatric research.

Main Results:

  • Strict intent-to-treat analysis is often infeasible in psychiatric trials due to data censoring caused by non-adherence.
  • Existing statistical methods for handling such censored data are inadequate or potentially misleading.
  • The context of psychiatric treatment management complicates objective outcome measurement.

Conclusions:

  • Investigators must prioritize obtaining complete follow-up data for all randomized patients, regardless of treatment adherence.
  • Efforts should focus on minimizing data censoring and ensuring data integrity for robust intent-to-treat analysis.
  • Adopting strategies for complete data collection is crucial for valid psychiatric clinical trial outcomes.